Article Information
History
- April 20, 2022.
Article Versions
- You are currently viewing Version 1 of this article (April 20, 2022 - 05:16).
- Version 2 (May 16, 2022 - 11:43).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Supreet Agarwal1,
- Lei Fang1,
- Kerry McGowen1,
- JuanJuan Yin1,
- Joel Bowman1,
- Anson T. Ku1,
- Aian Neil Alilin1,
- Eva Corey2,
- Martine Roudier2,
- Lawrence True3,
- Ruthy Dumpit4,
- Ilsa Coleman4,
- John Lee4,
- Peter S. Nelson4,
- Brian J. Capaldo1,
- Ilya S. Senatorov1,
- Adam G. Sowalsky1,
- Elaine M Hurt5 and
- Kathleen Kelly1,*
- 1Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH; Bethesda, Maryland, USA.
- 2Department of Urology, University of Washington, Seattle, WA 98195
- 3Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195
- 4Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98119
- 5AstraZeneca; Gaithersburg, Maryland, USA.
- ↵*Corresponding author. Email: kellyka{at}mail.nih.gov